<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Exp Diabetes Res</journal-id><journal-id journal-id-type="iso-abbrev">Exp Diabetes Res</journal-id><journal-id journal-id-type="publisher-id">EDR</journal-id><journal-title-group><journal-title>Experimental Diabetes Research</journal-title></journal-title-group><issn pub-type="ppub">1687-5214</issn><issn pub-type="epub">1687-5303</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">18350125</article-id><article-id pub-id-type="pmc">2266989</article-id><article-id pub-id-type="doi">10.1155/2008/672021</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Effects of Oral Glucose Load on Endothelial Function and on Insulin and Glucose Fluctuations in Healthy Individuals</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Major-Pedersen</surname><given-names>A.</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Ihlemann</surname><given-names>N.</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hermann</surname><given-names>T. S.</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Christiansen</surname><given-names>B.</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Dominguez</surname><given-names>H.</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kveiborg</surname><given-names>B.</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Nielsen</surname><given-names>D. B.</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Svendsen</surname><given-names>O. L.</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>K&#x000f8;ber</surname><given-names>L.</given-names></name><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Torp-Pedersen</surname><given-names>C.</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Cardiology Research Clinic Y, 
Bispebjerg University Hospital, 
2400 Copenhagen, NV, 
Denmark</aff><aff id="I2"><sup>2</sup>Cardiology Department P and Laboratory, 
Gentofte University Hospital, 
2900 Hellerup, 
Denmark</aff><aff id="I3"><sup>3</sup>Internal Medicine Clinic I, 
Bispebjerg University Hospital, 
2400 Copenhagen, NV, 
Denmark</aff><aff id="I4"><sup>4</sup>Cardiology department, 
Rigshospitalet Univeristy Hospital, 
2100 Copenhagen, 
Denmark</aff><author-notes><corresp id="cor1">*A. Major-Pedersen: <email>atmp@heart.dk</email></corresp><fn fn-type="other"><p>Recommended by George King</p></fn></author-notes><pub-date pub-type="ppub"><year>2008</year></pub-date><pub-date pub-type="epub"><day>4</day><month>3</month><year>2008</year></pub-date><volume>2008</volume><elocation-id>672021</elocation-id><history><date date-type="received"><day>22</day><month>7</month><year>2007</year></date><date date-type="accepted"><day>31</day><month>12</month><year>2007</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2008 A. Major-Pedersen et al.</copyright-statement><copyright-year>2008</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/3.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>
<italic>Background/aims</italic>. Postprandial hyperglycemia, an independent risk factor for cardiovascular disease, is accompanied by endothelial dysfunction. We studied the effect of oral glucose load on insulin and glucose fluctuations, and on postprandial endothelial function in healthy individuals in order to better understand and cope with the postprandial state in insulin resistant individuals. <italic>Methods</italic>. We assessed post-oral glucose load endothelial function (flow mediated dilation), plasma insulin, and blood glucose in 9 healthy subjects. <italic>Results</italic>. The largest increases in delta FMD values (fasting FMD value subtracted from postprandial FMD value) occurred at 3 hours after both glucose or placebo load, respectively: 4.80 &#x000b1; 1.41 (<italic>P</italic> = .009) and 2.34 &#x000b1; 1.47 (<italic>P</italic> = .15). Glucose and insulin 
concentrations achieved maximum peaks at one hour post-glucose load. <italic>Conclusion</italic>. Oral glucose load does not induce endothelial dysfunction in healthy individuals with mean insulin and glucose values of 5.6&#x02009;mmol/L and 27.2 mmol/L, respectively, 2 hours after glucose load.</p></abstract></article-meta></front><body><sec id="sec1"><title>1. INTRODUCTION</title><p>Postprandial hyperglycemia is an independent risk
factor for cardiovascular disease (CVD) in insulin-resistant individuals with
type 2 diabetes or with the prediabetic state, impaired glucose tolerance (IGT)
[<xref rid="B1" ref-type="bibr">1</xref>&#x02013;<xref rid="B10" ref-type="bibr">10</xref>].
In line with these epidemiologic data, several
studies have shown impairment of endothelial function, one of the
earliest markers of atherosclerosis [<xref rid="B11" ref-type="bibr">11</xref>] after a meal or glucose
challenge, in individuals with diabetes or IGT [<xref rid="B12" ref-type="bibr">12</xref>&#x02013;<xref rid="B17" ref-type="bibr">17</xref>].</p><p>Endothelial function following acute hyperglycemia
has also been studied in healthy individuals. Some groups have shown attenuation of endothelial function [<xref rid="B18" ref-type="bibr">18</xref>&#x02013;<xref rid="B26" ref-type="bibr">26</xref>],
whereas others have shown no change [<xref rid="B27" ref-type="bibr">27</xref>&#x02013;<xref rid="B31" ref-type="bibr">31</xref>]. A few studies have shown
acute hyperglycemia induced vasodilation in healthy individuals [<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B33" ref-type="bibr">33</xref>], and only 2 studies (in
vitro/ex vivo studies) have specifically reported glucose induced enhancement
of the endothelial function [<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B35" ref-type="bibr">35</xref>].</p><p>These seemingly conflicting results could be
attributed to differences in methodology and subject characteristics: diverging
periods of post-glucose load observations, varying periods of exposition to
different concentrations of glucose, diverging criteria in subject selection,
enabling versus blocking insulin&#x02019;s physiologic response, and finally
administrating oral glucose load versus intra-arterial or intravenous glucose
administration.</p><p>Endothelial dysfunction is a predictor of
cardiovascular risk; consequently, postprandial endothelial dysfunction might
be a very early marker of atherosclerosis and, thus, an early potential target
for the prevention of cardiovascular complications in insulin resistance. In
order to better understand and cope with postprandial endothelial dysfunction and
accompanying postprandial hyperinsulinemia and hyperglycemia in insulin
resistant individuals, we find it important to study postprandial glucose and
insulin fluctuations and postprandial endothelial function in healthy,
insulin-sensitive people.</p></sec><sec id="sec2"><title>2. MATERIAL AND METHODS</title><sec sec-type="subsection" id="subsec2.1"><title>2.1. Study population</title><p>Ten non-smoking subjects, with no history of cardiovascular or other chronic
disease, with no signs of current acute disease, and no familiar disposition to
glucose intolerance, were included after screening a total of 13 individuals.
We assessed blood pressure, ECG, oral glucose tolerance test, calculations of body
mass index (BMI) and homeostasis model assessment (HOMA), and biochemical
parameters. Three subjects were excluded: two due to total cholesterol &#x0003e; 6
mmo/L and one due to history of anorexia nervosa. Participants' characteristics
are shown on <xref ref-type="table" rid="tab1">Table 1</xref>. All subjects gave written informed consent and the study
was approved by the ethics committee for Copenhagen and Frederiksberg counties.</p></sec><sec sec-type="subsection" id="subsec2.2"><title>2.2. Study design</title><p>Cross over study, <italic>n</italic> = 10. Subjects met on 2 separate days at 8:00
am after a 12-hour fast and after at least 18 hours abstinence from
exercise. On the &#x0201c;glucose day&#x0201d;, endothelial function was measured before a 75&#x02009;g
oral glucose load (200&#x02009;mL) and again at 1, 2, 3, and 4 hours after glucose
load. On the &#x0201c;placebo day&#x0201d;, the same procedure was followed, but the 75&#x02009;g
glucose was substituted with placebo (200&#x02009;mL tap water) as shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>. The first FMD measurement of
the day commenced between 8:30 and 9:00 am, glucose/H<sub>2</sub>0 was given between 9:00 and 9:30, and the last FMD measurement of
the day ended between 13:30 and 14:00.</p><p>We extrapolated our post-glucose load findings to
postprandial effects, since plasma glucose concentrations measured 2 hours after
the ingestion of 75&#x02009;g glucose have been found to be closely related to those
measured after a standardized mixed meal [<xref rid="B36" ref-type="bibr">36</xref>].</p></sec><sec sec-type="subsection" id="subsec2.3"><title>2.3. Measurements of endothelial function</title><p>We used the <bold>f</bold>low <bold>m</bold>ediated <bold>d</bold>ilation
(FMD) method [<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B38" ref-type="bibr">38</xref>]. 20 minutes after supine rest,
a pneumatic cuff was placed distal to the antecubital fossa, a 7.5&#x02009;MHz linear
array transducer (Cypress/Siemens, Siemens Medical Solutions USA, Inc. Mountain
View, CA) was placed proximal to the antecubital fossa, and the brachial artery
was viewed in a 2-dimensional (B-mode) longitudinal plane. A baseline picture
was saved to ensure that the same brachial picture was found in the successive
studies. After acquiring a two-minute baseline image, the cuff was rapidly
inflated to 300&#x02009;mmHg (VBM tourniquets, Braun Scandinavia) for 5 minutes,
followed by rapid cuff deflation. Images were registered during 4 minutes after
cuff deflation. Brachial diameters (at baseline and after cuff-deflation) were
measured simultaneously by automated software (VIA online flow mediated dilation
software, MD Medic) [<xref rid="B39" ref-type="bibr">39</xref>]. This software enabled us to
precisely localize the greatest EDV since dilation was depicted graphically (as
well as numerically).</p><p>The following formula was used to calculate relative
change in FMD (expressed in %): ((Peak post cuff-deflation diameter &#x02212; basline diameter)/baseline diameter) &#x000d7; 100 [<xref rid="B40" ref-type="bibr">40</xref>].</p><p>An intravenous cannula was inserted into a large
antecubital vein in the left arm for blood sampling.</p></sec><sec sec-type="subsection" id="subsec2.4"><title>2.4. Biochemical measurements</title><p>Blood samples were drawn on both days before oral glucose load/placebo
administration and at 15, 30, 60, 120, 180, and 240 minutes after plasma was
separated after complete clot formation, subsequent to centrifugation, and
thereafter frozen at &#x02212;80&#x000b0;C for posterior analysis of insulin (Immulite 2000, DPC
Scandinavia, Denmark).</p><p>Whole venous blood glucose was measured at the
aforementioned times with HemoCue glucose (HemoCue AB, Angelholm, Sweden).</p></sec><sec sec-type="subsection" id="subsec2.5"><title>2.5. Data analysis</title><p>Data are presented as mean &#x000b1; SEM. Comparisons between time points on the same curve (pre-oral glucose load, 1hPG,
2hPG, 3hPG, and 4hPG) for FMD, insulin, and glucose were evaluated with paired student <italic>t</italic> test for each curve separately. The level of statistical significance
used was <italic>P</italic> &#x0003c; .05. For comparison of FMD time response studies between
the 2 curves (post-glucose curve versus post-placebo curve), we used MIXED MODEL analysis (SAS statistical
software version 9.1, SAS Institute, Cary, NC, USA).</p><p>Model assumptions of homogeneity of variance and
normal distribution of residuals were checked graphically. Subjects entered the
model as random effect as did the interaction between subject and time. Time
and experimental protocols
(glucose versus placebo) were entered as fixed effects.</p></sec></sec><sec id="sec3"><title>3. RESULTS</title><sec sec-type="subsection" id="subsec3.1"><title>3.1. Endothelial function</title><p>Delta FMD values (fasting FMD value subtracted from postprandial FMD value) &#x000b1; SEM for
post-glucose load and post-placebo load showed increasing FMD delta values for
both days (see <xref ref-type="table" rid="tab2">Table 2</xref>). The largest
post-glucose load increase occurred at 3hPG (<italic>P</italic> = .009); compared to baseline, the increase was
already significant at 1hPG (<italic>P</italic> = 0.03). The largest post-placebo
increase also occurred at 3 hours post-placebo (<italic>P</italic> = .15) but was not significant (see <xref ref-type="table" rid="tab2">Table 2</xref>). When we compared the two curves employing mixed
models (post-glucose load curve versus post-placebo load curve), we found the
curves to be statistically different (<italic>P</italic> = .0007).</p></sec><sec sec-type="subsection" id="subsec3.2"><title>3.2. Metabolic parameters</title><sec sec-type="subsubsection" id="subsubsec3.2.1"><title>3.2.1. Glucose</title><p>Post-glucose load mean blood
glucose concentration values showed a significant increase at both 1hPG (<italic>P</italic> =
.03) and 2hPG (<italic>P</italic> = .002). Conversely, a significant fall in blood sugar
was observed at 4hPG (<italic>P</italic> = .002, <italic>n</italic> = 6 since the study was interrupted
before the fourth postprandial hour in 3 subjects due to symptomatic
hypoglycemia). As expected, post-placebo load values showed no significant
change in blood glucose concentrations in the fasting state (see <xref ref-type="table" rid="tab2">Table 2</xref>).</p></sec><sec sec-type="subsubsection" id="subsubsec3.2.2"><title>3.2.2. Insulin</title><p>Mean insulin concentration post-glucose load values showed a marked increase at 1hPG (<italic>P</italic> = .0006) and fell rapidly thereafter, achieving pre-glucose-like
values by 3hPG. Post-placebo load values fell across the 4 hour post-load
period, which was already apparent at one hour post placebo load (<italic>P</italic> = .0006) 
(<xref ref-type="table" rid="tab2">Table 2</xref>).</p></sec></sec></sec><sec id="sec4"><title>4. DISCUSSION</title><p>Our principal finding was that oral glucose load did
not impair endothelial function in conduit arteries in our group of healthy,
insulin-sensitive individuals with mean 2hPG of
5.58&#x02009;mmol/L. We found maximum glucose and insulin peak concentrations at
1hPG. Furthermore our findings imply that oral glucose load might enhance
endothelial function in these individuals.</p><p>Many studies have examined
the effect of acute hyperglycemia on the healthy endothelium [<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B41" ref-type="bibr">41</xref>]. These studies, however,
cannot be directly compared to ours since both the methodology and the purpose
of the studies diverge from our study. The aforementioned studies demonstrated
that hyperglycemia induced impaired endothelial function, in healthy
individuals, by either applying a local glucose/dextrose clamp or by
intra-arterial glucose infusion, hence obtaining elevated hyperglycemic values
(7.0 to 16.7&#x02009;mmol/L). Yet, postprandial hormonal
mechanisms, such as those leading to the &#x0201c;incretin effect&#x0201d; [<xref rid="B42" ref-type="bibr">42</xref>], may not be triggered when
examined through the hyperglycemic clamp technique or local hyperglycemia. Some
of these studies [<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B41" ref-type="bibr">41</xref>] had 
also administered systemic ocreotide to suppress insulin secretion response to hyperglycemia. We
did not find it appropriate to inhibit insulin secretion in order to study the
physiologic endothelial post-glucose load response in healthy individuals since
we suspected that the post-oral-glucose load insulin response might be pivotal
in contributing to endothelial dependent vasodilation. Aside from keeping all
hormonal responses intact, we chose to investigate post-glucose load
endothelial function up to 4 hours after glucose load, because we were aware of
the possibility that the endothelial response might not necessarily occur
simultaneously with the increasing glucose and insulin concentrations. Our
study is further strengthened by the fact that &#x0201c;time to peak&#x0201d; (the time it
takes to achieve maximal dilation after cuff-deflation) varies individually, and
that, by using our automated edge-detecting software, we have been sure of
appreciating the largest dilation at each FMD measurement. Earlier studies
using the FMD method have been forced to find a spot more or less blindly,
between 40 and 90 seconds post cuff-deflation, for their measurements [<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B25" ref-type="bibr">25</xref>].</p><p>As mentioned, differences in subject selection,
particularly regarding postprandial blood glucose concentrations, might too
have contributed to the apparently diverse findings reported in our study and
other studies. A continuous relationship between increasing fasting and
postprandial glucose concentrations and the risk of cardiovascular mortality in
healthy, normoglycemic subjects has been documented [<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B44" ref-type="bibr">44</xref>]. Furthermore, a strong
inverse relationship has been demonstrated between glucose levels, and
endothelial function and intima media thickness (IMT) across the normoglycemic
continuum; this was marked already at the 5.2&#x02009;mmol/cut-off, and was even more
significant with fasting glucose above 5.7&#x02009;mmol/L [<xref rid="B45" ref-type="bibr">45</xref>]. Interestingly, 
a directly proportional risk gradient between CVD and postprandial glucose has been
evidenced at1hPG [<xref rid="B9" ref-type="bibr">9</xref>].</p><p>In accordance with our selection criteria, our
subjects were metabolic healthier, with lower mean fasting and postprandial
glucose values than those in studies which employed a methodology similar to
ours and, yet, demonstrated impaired endothelial function [<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>]. To illustrate, Title&#x02019;s study [<xref rid="B19" ref-type="bibr">19</xref>] reported impaired endothelial
function after oral glucose loading in 10 study subjects with a mean 1hPG of
7.9&#x02009;mmol/L (as opposed to 6.2&#x02009;mmol/L in our subjects). Thereby, the apparently
contradictory results between Title's study and ours are actually
complementary.</p><p>A limitation to our study is that it does not shed
light on the cellular mechanisms responsible for the postprandial endothelial
response. Yet, several mechanistic studies support our findings. Taubert&#x02019;s
group [<xref rid="B34" ref-type="bibr">34</xref>], for example, demonstrated
that insulin's NO vasodilatory effect was augmented in the presence of relative
hyperglycemia [<xref rid="B34" ref-type="bibr">34</xref>]. Indeed,
in our subjects, there was a short and modest postprandial plasma glucose
spike, followed by a larger postprandial hyperinsulinemic spike, which, in
conjunction, led to an enhancement of the endothelial function when compared to
baseline endothelial function. Conversely, our group [<xref rid="B46" ref-type="bibr">46</xref>] has 
previously proposed that persistent hyperglycemia inhibits PI3K-dependent signaling. Taubert's group
reported that glucose and insulin stimulated NO release was impaired in the presence of hyperglycemia lasting
beyond 2 hours, and that acute hyperglycemia did not increase NO release after
prolonged exposure to hyperglycemia, leading them to suggest that enhanced
superoxide generation in chronic hyperglycemia could be responsible for
accelerated NO degradation. These findings could explain why studies where hyperglycemic clamps were employed,
and/or examined subjects with relatively high postprandial values, have not
found enhanced endothelial function [<xref rid="B18" ref-type="bibr">18</xref>&#x02013;<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B47" ref-type="bibr">47</xref>].</p><p>The greatest increment in endothelial function in our
study occurred at 3 hours post-glucose load when glucose concentrations were
back to baseline levels yet with insulin concentrations still 6 times higher
than baseline insulin concentrations. Furthermore we observed a positive
post-glucose load delta value at the cessation of the study (4hPG) for FMD and
insulin concentrations. Interestingly, Cardillo et al. [<xref rid="B48" ref-type="bibr">48</xref>] found maximal insulin dilator effect after 2
hours of insulin infusion, leading them to postulate that insulin has a
relatively slow-onset vasodilator effect. Accordingly, four hours of sustained
hyperinsulinemia in the healthy has been shown to induce endothelial dependent
vasodilation [<xref rid="B50" ref-type="bibr">49</xref>]. These observations could therefore explain our positive
findings and why research groups that have limited their postprandial
endothelial studies to 2 hours or less after a meal/glucose load [<xref rid="B24" ref-type="bibr">24</xref>] have not observed insulin
induced endothelium dependent vasodilation following a hyperglycemic spike.</p><p>As aforementioned, post-glucose load glucose
concentrations correlate closely to post-standardized meal glucose
concentrations; yet we cannot directly compare our results with studies that
have used standardized meals since these include lipids. Admitting that a
standardized meal would have reflected a truer postprandial response, a
standardized meal would have obscured the action of glucose alone on the
endotheliuem, since it has been demonstrated that postprandial hyperlipidemia
induces postprandial endothelial dysfunction in the healthy endothelium [<xref rid="B51" ref-type="bibr">50</xref>&#x02013;<xref rid="B53" ref-type="bibr">52</xref>].</p></sec><sec id="sec5"><title>5. CONCLUSION</title><p>In short, we find that endothelial dysfunction is not
a normal, physiologic, post-glucose load response. Instead, this study finds
preserved post-glucose load endothelial function, thus implying that sugar derived from 
meals does not promote endothelial dysfunction, providing that postprandial
insulin and glucose responses are preserved. It seems that the interaction of
glucose and insulin on the endothelial function is affected both by the
magnitude of glucose and insulin concentrations, and by the duration of
exposition to these.</p><p>The immediate question arising from this study is
whether by targeting both postprandial glucose and insulin peaks in insulin
resistant individuals, so that both postprandial peaks resemble those of
insulin sensitive individuals, enhances postprandial endothelial function. There
is a pressing need for a greater therapeutic focus on the postprandial state,
accompanied by a redefinition of the &#x0201c;normal&#x0201d; postprandial state, marking the
true threshold for the onset of cardiovascular risk.</p></sec></body><back><ack><title>ACKNOWLEDGMENT</title><p>This work is supported by the Danish Diabetes Association.</p></ack><glossary><title>ABBREVIATIONS</title><def-list><def-item><term>1hPG, 2hPG:</term><def><p>1-hour and 2-hour glucose values after an oral 75 glucose load</p></def></def-item><def-item><term>3hPG, 4hPG:</term><def><p>3-hour and 4-hour glucose values after an oral 75 glucose load</p></def></def-item><def-item><term>CVD:</term><def><p>Cardiovascular disease</p></def></def-item><def-item><term>FMD:</term><def><p>Flow mediated dilation</p></def></def-item><def-item><term>HOMA:</term><def><p>Homeostasis model assessment</p></def></def-item><def-item><term>IGT:</term><def><p>Impaired glucose tolerance</p></def></def-item><def-item><term>NO:</term><def><p>Nitric oxide</p></def></def-item><def-item><term>PI3K:</term><def><p>Phsophatidylnositol 3&#x02032;-OH kinase</p></def></def-item></def-list></glossary><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiao</surname><given-names>Q</given-names></name><name><surname>Larsen</surname><given-names>S</given-names></name><name><surname>Borch-Johnsen</surname><given-names>K</given-names></name><etal/></person-group><article-title>Glucose tolerance and cardiovascular mortality. Comparison of fasting and 2-hour diagnostic criteria</article-title><source><italic>Archives of Internal Medicine</italic></source><year>2001</year><volume>161</volume><issue>3</issue><fpage>397</fpage><lpage>405</lpage><pub-id pub-id-type="pmid">11176766</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonora</surname><given-names>E</given-names></name><name><surname>Muggeo</surname><given-names>M</given-names></name></person-group><article-title>Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence</article-title><source><italic>Diabetologia</italic></source><year>2001</year><volume>44</volume><issue>12</issue><fpage>2107</fpage><lpage>2114</lpage><pub-id pub-id-type="pmid">11793012</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>BL</given-names></name><name><surname>Abbott</surname><given-names>RD</given-names></name><name><surname>Fujimoto</surname><given-names>W</given-names></name><etal/></person-group><article-title>The American diabetes association and world health organization classifications for diabetes: their impact on diabetes prevalence and total and cardiovascular disease mortality in elderly Japanese-American men</article-title><source><italic>Diabetes Care</italic></source><year>2002</year><volume>25</volume><issue>6</issue><fpage>951</fpage><lpage>955</lpage><pub-id pub-id-type="pmid">12032097</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tominaga</surname><given-names>M</given-names></name><name><surname>Eguchi</surname><given-names>H</given-names></name><name><surname>Manaka</surname><given-names>H</given-names></name><name><surname>Igarashi</surname><given-names>K</given-names></name><name><surname>Kato</surname><given-names>T</given-names></name><name><surname>Sekikawa</surname><given-names>A</given-names></name></person-group><article-title>Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: the funagata diabetes study</article-title><source><italic>Diabetes Care</italic></source><year>1999</year><volume>22</volume><issue>6</issue><fpage>920</fpage><lpage>924</lpage><pub-id pub-id-type="pmid">10372242</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Vegt</surname><given-names>F</given-names></name><name><surname>Dekker</surname><given-names>JM</given-names></name><name><surname>Ruh&#x000e9;</surname><given-names>HG</given-names></name><etal/></person-group><article-title>Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn study</article-title><source><italic>Diabetologia</italic></source><year>1999</year><volume>42</volume><issue>8</issue><fpage>926</fpage><lpage>931</lpage><pub-id pub-id-type="pmid">10491751</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>JE</given-names></name><name><surname>Hodge</surname><given-names>AM</given-names></name><name><surname>De Courten</surname><given-names>M</given-names></name><name><surname>Chitson</surname><given-names>P</given-names></name><name><surname>Zimmet</surname><given-names>PZ</given-names></name></person-group><article-title>Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality</article-title><source><italic>Diabetologia</italic></source><year>1999</year><volume>42</volume><issue>9</issue><fpage>1050</fpage><lpage>1054</lpage><pub-id pub-id-type="pmid">10447514</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coutinho</surname><given-names>M</given-names></name><name><surname>Gerstein</surname><given-names>HC</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Yusuf</surname><given-names>S</given-names></name></person-group><article-title>The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years</article-title><source><italic>Diabetes Care</italic></source><year>1999</year><volume>22</volume><issue>2</issue><fpage>233</fpage><lpage>240</lpage><pub-id pub-id-type="pmid">10333939</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanefeld</surname><given-names>M</given-names></name><name><surname>Koehler</surname><given-names>C</given-names></name><name><surname>Schaper</surname><given-names>F</given-names></name><name><surname>Fuecker</surname><given-names>K</given-names></name><name><surname>Henkel</surname><given-names>E</given-names></name><name><surname>Temelkova-Kurktschiev</surname><given-names>T</given-names></name></person-group><article-title>Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals</article-title><source><italic>Atherosclerosis</italic></source><year>1999</year><volume>144</volume><issue>1</issue><fpage>229</fpage><lpage>235</lpage><pub-id pub-id-type="pmid">10381296</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>BL</given-names></name><name><surname>Lau</surname><given-names>N</given-names></name><name><surname>Burchfiel</surname><given-names>CM</given-names></name><etal/></person-group><article-title>Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu heart program</article-title><source><italic>Diabetes Care</italic></source><year>1999</year><volume>22</volume><issue>8</issue><fpage>1262</fpage><lpage>1265</lpage><pub-id pub-id-type="pmid">10480768</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Temelkova-Kurktschiev</surname><given-names>T</given-names></name></person-group><article-title>Significance of postprandial glucose peaks for development of diabetic macroangiopathy</article-title><source><italic>Therapeutische Umschau</italic></source><year>2002</year><volume>59</volume><fpage>411</fpage><lpage>414</lpage><pub-id pub-id-type="pmid">12235733</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaenzer</surname><given-names>H</given-names></name><name><surname>Neumayr</surname><given-names>G</given-names></name><name><surname>Marschang</surname><given-names>P</given-names></name><etal/></person-group><article-title>Effect of insulin therapy on endothelium-dependent dilation in type 2 diabetes mellitus</article-title><source><italic>The American Journal of Cardiology</italic></source><year>2002</year><volume>89</volume><issue>4</issue><fpage>431</fpage><lpage>434</lpage><pub-id pub-id-type="pmid">11835925</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceriello</surname><given-names>A</given-names></name></person-group><article-title>Acute hyperglycaemia: a &#x02018;new&#x02019; risk factor during myocardial infarction</article-title><source><italic>European Heart Journal</italic></source><year>2005</year><volume>26</volume><issue>4</issue><fpage>328</fpage><lpage>331</lpage><pub-id pub-id-type="pmid">15618047</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceriello</surname><given-names>A</given-names></name><name><surname>Cavarape</surname><given-names>A</given-names></name><name><surname>Martinelli</surname><given-names>L</given-names></name><etal/></person-group><article-title>The post-prandial state in type 2 diabetes and endothelial dysfunction: effects of insulin aspart</article-title><source><italic>Diabetic Medicine</italic></source><year>2004</year><volume>21</volume><issue>2</issue><fpage>171</fpage><lpage>175</lpage><pub-id pub-id-type="pmid">14984453</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimabukuro</surname><given-names>M</given-names></name><name><surname>Higa</surname><given-names>N</given-names></name><name><surname>Chinen</surname><given-names>I</given-names></name><name><surname>Yamakawa</surname><given-names>K</given-names></name><name><surname>Takasu</surname><given-names>N</given-names></name></person-group><article-title>Effects of a single administration of acarbose on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients: a randomized crossover study</article-title><source><italic>Journal of Clinical Endocrinology and Metabolism</italic></source><year>2006</year><volume>91</volume><issue>3</issue><fpage>837</fpage><lpage>842</lpage><pub-id pub-id-type="pmid">16368744</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimabukuro</surname><given-names>M</given-names></name><name><surname>Higa</surname><given-names>N</given-names></name><name><surname>Takasu</surname><given-names>N</given-names></name><name><surname>Tagawa</surname><given-names>T</given-names></name><name><surname>Ueda</surname><given-names>S</given-names></name></person-group><article-title>A single dose of nateglinide improves post-challenge glucose metabolism and endothelial dysfunction in type 2 diabetic patients</article-title><source><italic>Diabetic Medicine</italic></source><year>2004</year><volume>21</volume><issue>9</issue><fpage>983</fpage><lpage>986</lpage><pub-id pub-id-type="pmid">15317602</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S-H</given-names></name><name><surname>Park</surname><given-names>K-W</given-names></name><name><surname>Kim</surname><given-names>Y-S</given-names></name><etal/></person-group><article-title>Effects of acute hyperglycemia on endothelium-dependent vasodilation in patients with diabetes mellitus or impaired glucose metabolism</article-title><source><italic>Endothelium</italic></source><year>2003</year><volume>10</volume><issue>2</issue><fpage>65</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">12791513</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wascher</surname><given-names>TC</given-names></name><name><surname>Schmoelzer</surname><given-names>I</given-names></name><name><surname>Wiegratz</surname><given-names>A</given-names></name><etal/></person-group><article-title>Reduction of postchallenge hyperglycaemia prevents acute endothelial dysfunction in subjects with impaired glucose tolerance</article-title><source><italic>European Journal of Clinical Investigation</italic></source><year>2005</year><volume>35</volume><issue>9</issue><fpage>551</fpage><lpage>557</lpage><pub-id pub-id-type="pmid">16128861</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giugliano</surname><given-names>D</given-names></name><name><surname>Marfella</surname><given-names>R</given-names></name><name><surname>Coppola</surname><given-names>L</given-names></name><etal/></person-group><article-title>Vascular effects of acute hyperglycemia in humans are reversed by L-arginine: evidence for reduced availability of nitric oxide during hyperglycemia</article-title><source><italic>Circulation</italic></source><year>1997</year><volume>95</volume><issue>7</issue><fpage>1783</fpage><lpage>1790</lpage><pub-id pub-id-type="pmid">9107164</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Title</surname><given-names>LM</given-names></name><name><surname>Cummings</surname><given-names>PM</given-names></name><name><surname>Giddens</surname><given-names>K</given-names></name><name><surname>Nassar</surname><given-names>BA</given-names></name></person-group><article-title>Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E</article-title><source><italic>Journal of the American College of Cardiology</italic></source><year>2000</year><volume>36</volume><issue>7</issue><fpage>2185</fpage><lpage>2191</lpage><pub-id pub-id-type="pmid">11127459</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>SB</given-names></name><name><surname>Goldfine</surname><given-names>AB</given-names></name><name><surname>Timimi</surname><given-names>FK</given-names></name><etal/></person-group><article-title>Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo</article-title><source><italic>Circulation</italic></source><year>1998</year><volume>97</volume><issue>17</issue><fpage>1695</fpage><lpage>1701</lpage><pub-id pub-id-type="pmid">9591763</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawano</surname><given-names>H</given-names></name><name><surname>Motoyama</surname><given-names>T</given-names></name><name><surname>Hirashima</surname><given-names>O</given-names></name><etal/></person-group><article-title>Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery</article-title><source><italic>Journal of the American College of Cardiology</italic></source><year>1999</year><volume>34</volume><issue>1</issue><fpage>146</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">10400004</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beckman</surname><given-names>JA</given-names></name><name><surname>Creager</surname><given-names>MA</given-names></name><name><surname>Libby</surname><given-names>P</given-names></name></person-group><article-title>Diabetes and atherosclerosis epidemiology, pathophysiology, and management</article-title><source><italic>Journal of the American Medical Association</italic></source><year>2002</year><volume>287</volume><issue>19</issue><fpage>2570</fpage><lpage>2581</lpage><pub-id pub-id-type="pmid">12020339</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beckman</surname><given-names>JA</given-names></name><name><surname>Goldfine</surname><given-names>AB</given-names></name><name><surname>Gordon</surname><given-names>MB</given-names></name><name><surname>Garrett</surname><given-names>LA</given-names></name><name><surname>Creager</surname><given-names>MA</given-names></name></person-group><article-title>Inhibition of protein kinase C<italic>&#x003b2;</italic> prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans</article-title><source><italic>Clinical Research</italic></source><year>2002</year><volume>90</volume><fpage>107</fpage><lpage>111</lpage></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akbari</surname><given-names>CM</given-names></name><name><surname>Saouaf</surname><given-names>R</given-names></name><name><surname>Barnhill</surname><given-names>DF</given-names></name><name><surname>Newman</surname><given-names>PA</given-names></name><name><surname>LoGerfo</surname><given-names>FW</given-names></name><name><surname>Veves</surname><given-names>A</given-names></name></person-group><article-title>Endothelium-dependent vasodilatation is impaired in both microcirculation and macrocirculation during acute hyperglycemia</article-title><source><italic>Journal of Vascular Surgery</italic></source><year>1998</year><volume>28</volume><issue>4</issue><fpage>687</fpage><lpage>694</lpage><pub-id pub-id-type="pmid">9786265</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceriello</surname><given-names>A</given-names></name><name><surname>Taboga</surname><given-names>C</given-names></name><name><surname>Tonutti</surname><given-names>L</given-names></name><etal/></person-group><article-title>Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment</article-title><source><italic>Circulation</italic></source><year>2002</year><volume>106</volume><issue>10</issue><fpage>1211</fpage><lpage>1218</lpage><pub-id pub-id-type="pmid">12208795</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ihlemann</surname><given-names>N</given-names></name><name><surname>Rask-Madsen</surname><given-names>C</given-names></name><name><surname>Perner</surname><given-names>A</given-names></name><etal/></person-group><article-title>Tetrahydrobiopterin restores endothelial dysfunction induced by an oral glucose challenge in healthy subjects</article-title><source><italic>American Journal of Physiology&#x02014;Heart and Circulatory Physiology</italic></source><year>2003</year><volume>285</volume><issue>2</issue><fpage>H875</fpage><lpage>H882</lpage><pub-id pub-id-type="pmid">12730050</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houben</surname><given-names>AJHM</given-names></name><name><surname>Schaper</surname><given-names>NC</given-names></name><name><surname>de Haan</surname><given-names>CHA</given-names></name><etal/></person-group><article-title>Local 24-h hyperglycemia does not affect endothelium-dependent or&#x02014;independent vasoreactivity in humans</article-title><source><italic>American Journal of Physiology&#x02014;Heart and Circulatory Physiology</italic></source><year>1996</year><volume>270</volume><issue>6</issue><fpage>H2014</fpage><lpage>H2020</lpage></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charkoudian</surname><given-names>N</given-names></name><name><surname>Vella</surname><given-names>A</given-names></name><name><surname>Reed</surname><given-names>AS</given-names></name><etal/></person-group><article-title>Cutaneous vascular function during acute hyperglycemia in healthy young adults</article-title><source><italic>Journal of Applied Physiology</italic></source><year>2002</year><volume>93</volume><issue>4</issue><fpage>1243</fpage><lpage>1250</lpage><pub-id pub-id-type="pmid">12235021</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bagg</surname><given-names>W</given-names></name><name><surname>Whalley</surname><given-names>GA</given-names></name><name><surname>Sathu</surname><given-names>A</given-names></name><name><surname>Gamble</surname><given-names>G</given-names></name><name><surname>Sharpe</surname><given-names>N</given-names></name><name><surname>Braatvedt</surname><given-names>GD</given-names></name></person-group><article-title>The effect of acute hyperglycaemia on brachial artery flow mediated dilatation in normal volunteers</article-title><source><italic>Australian and New Zealand Journal of Medicine</italic></source><year>2000</year><volume>30</volume><issue>3</issue><fpage>344</fpage><lpage>350</lpage><pub-id pub-id-type="pmid">10914752</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reed</surname><given-names>AS</given-names></name><name><surname>Charkoudian</surname><given-names>N</given-names></name><name><surname>Vella</surname><given-names>A</given-names></name><name><surname>Shah</surname><given-names>P</given-names></name><name><surname>Rizza</surname><given-names>RA</given-names></name><name><surname>Joyner</surname><given-names>MJ</given-names></name></person-group><article-title>Forearm vascular control during acute hyperglycemia in healthy humans</article-title><source><italic>American Journal of Physiology&#x02014;Endocrinology and Metabolism</italic></source><year>2004</year><volume>286</volume><issue>3</issue><fpage>E472</fpage><lpage>E480</lpage><pub-id pub-id-type="pmid">14583439</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siafarikas</surname><given-names>A</given-names></name><name><surname>Watts</surname><given-names>K</given-names></name><name><surname>Beye</surname><given-names>P</given-names></name><name><surname>Jones</surname><given-names>TW</given-names></name><name><surname>Davis</surname><given-names>EA</given-names></name><name><surname>Green</surname><given-names>DJ</given-names></name></person-group><article-title>Lack of effect of oral glucose loading on conduit vessel endothelial function in healthy subjects</article-title><source><italic>Clinical Science</italic></source><year>2004</year><volume>107</volume><issue>2</issue><fpage>191</fpage><lpage>196</lpage><pub-id pub-id-type="pmid">15068394</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>RP</given-names></name><name><surname>Hausberg</surname><given-names>M</given-names></name><name><surname>Sinkey</surname><given-names>CA</given-names></name><name><surname>Anderson</surname><given-names>EA</given-names></name></person-group><article-title>Hyperglycemia without hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans</article-title><source><italic>Journal of Diabetes and Its Complications</italic></source><year>1999</year><volume>13</volume><issue>1</issue><fpage>17</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">10232705</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Veen</surname><given-names>S</given-names></name><name><surname>Fr&#x000f6;lich</surname><given-names>M</given-names></name><name><surname>Chang</surname><given-names>PC</given-names></name></person-group><article-title>Acute hyperglycaemia in the forearm induces vasodilation that is not modified by hyperinsulinaemia</article-title><source><italic>Journal of Human Hypertension</italic></source><year>1999</year><volume>13</volume><issue>4</issue><fpage>263</fpage><lpage>268</lpage><pub-id pub-id-type="pmid">10333345</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taubert</surname><given-names>D</given-names></name><name><surname>Rosenkranz</surname><given-names>A</given-names></name><name><surname>Berkels</surname><given-names>R</given-names></name><name><surname>Roesen</surname><given-names>R</given-names></name><name><surname>Sch&#x000f6;mig</surname><given-names>E</given-names></name></person-group><article-title>Acute effects of glucose and insulin on vascular endothelium</article-title><source><italic>Diabetologia</italic></source><year>2004</year><volume>47</volume><issue>12</issue><fpage>2059</fpage><lpage>2071</lpage><pub-id pub-id-type="pmid">15662548</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cipolla</surname><given-names>MJ</given-names></name><name><surname>Porter</surname><given-names>JM</given-names></name><name><surname>Osol</surname><given-names>G</given-names></name></person-group><article-title>High glucose concentrations dilate cerebral arteries and diminish myogenic tone through an endothelial mechanism</article-title><source><italic>Stroke</italic></source><year>1997</year><volume>28</volume><issue>2</issue><fpage>405</fpage><lpage>410</lpage><comment>discussion 410-411.</comment><pub-id pub-id-type="pmid">9040698</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolever</surname><given-names>TMS</given-names></name><name><surname>Chiasson</surname><given-names>J-L</given-names></name><name><surname>Csima</surname><given-names>A</given-names></name><etal/></person-group><article-title>Variation of postprandial plasma glucose, palatability, and symptoms associated with a standardized mixed test meal versus 75 g oral glucose</article-title><source><italic>Diabetes Care</italic></source><year>1998</year><volume>21</volume><issue>3</issue><fpage>336</fpage><lpage>340</lpage><pub-id pub-id-type="pmid">9540012</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celermajer</surname><given-names>DS</given-names></name><name><surname>Sorensen</surname><given-names>KE</given-names></name><name><surname>Gooch</surname><given-names>VM</given-names></name><etal/></person-group><article-title>Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis</article-title><source><italic>Lancet</italic></source><year>1992</year><volume>340</volume><issue>8828</issue><fpage>1111</fpage><lpage>1115</lpage><pub-id pub-id-type="pmid">1359209</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corretti</surname><given-names>MC</given-names></name><name><surname>Anderson</surname><given-names>TJ</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><etal/></person-group><article-title>Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force</article-title><source><italic>Journal of the American College of Cardiology</italic></source><year>2002</year><volume>39</volume><issue>2</issue><fpage>257</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">11788217</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newey</surname><given-names>VR</given-names></name><name><surname>Nassiri</surname><given-names>DK</given-names></name></person-group><article-title>Online artery diameter measurement in ultrasound images using artificial neural networks</article-title><source><italic>Ultrasound in Medicine and Biology</italic></source><year>2002</year><volume>28</volume><issue>2</issue><fpage>209</fpage><lpage>216</lpage><pub-id pub-id-type="pmid">11937284</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lind</surname><given-names>L</given-names></name><name><surname>Hall</surname><given-names>J</given-names></name><name><surname>Larsson</surname><given-names>A</given-names></name><name><surname>Annuk</surname><given-names>M</given-names></name><name><surname>Fellstr&#x000f6;m</surname><given-names>B</given-names></name><name><surname>Lithell</surname><given-names>H</given-names></name></person-group><article-title>Evaluation of endothelium-dependent vasodilation in the human peripheral circulation</article-title><source><italic>Clinical Physiology</italic></source><year>2000</year><volume>20</volume><issue>6</issue><fpage>440</fpage><lpage>448</lpage><pub-id pub-id-type="pmid">11100391</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname><given-names>K</given-names></name><name><surname>Nappo</surname><given-names>F</given-names></name><name><surname>Marfella</surname><given-names>R</given-names></name><etal/></person-group><article-title>Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress</article-title><source><italic>Circulation</italic></source><year>2002</year><volume>106</volume><issue>16</issue><fpage>2067</fpage><lpage>2072</lpage><pub-id pub-id-type="pmid">12379575</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elrick</surname><given-names>H</given-names></name><name><surname>Stimmler</surname><given-names>L</given-names></name><name><surname>Hlad</surname><given-names>CJ</given-names><suffix>Jr.</suffix></name><name><surname>Arai</surname><given-names>Y</given-names></name></person-group><article-title>Plasma insulin response to oral and intravenous glucose administration</article-title><source><italic>Journal of Clinical Endocrinology &#x00026; Metabolism</italic></source><year>1964</year><volume>24</volume><fpage>1076</fpage><lpage>1082</lpage><pub-id pub-id-type="pmid">14228531</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuller</surname><given-names>JH</given-names></name><name><surname>Shipley</surname><given-names>MJ</given-names></name><name><surname>Rose</surname><given-names>G</given-names></name><name><surname>Jarrett</surname><given-names>RJ</given-names></name><name><surname>Keen</surname><given-names>H</given-names></name></person-group><article-title>Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study</article-title><source><italic>Lancet</italic></source><year>1980</year><volume>1</volume><issue>8183</issue><fpage>1373</fpage><lpage>1376</lpage><pub-id pub-id-type="pmid">6104171</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Py&#x000f6;r&#x000e4;l&#x000e4;</surname><given-names>M</given-names></name><name><surname>Miettinen</surname><given-names>H</given-names></name><name><surname>Halonen</surname><given-names>P</given-names></name><name><surname>Laakso</surname><given-names>M</given-names></name><name><surname>Py&#x000f6;r&#x000e4;l&#x000e4;</surname><given-names>K</given-names></name></person-group><article-title>Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki policemen study</article-title><source><italic>Arteriosclerosis, Thrombosis, and Vascular Biology</italic></source><year>2000</year><volume>20</volume><issue>2</issue><fpage>538</fpage><lpage>544</lpage></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>GN</given-names></name><name><surname>Chook</surname><given-names>P</given-names></name><name><surname>Qiao</surname><given-names>M</given-names></name><etal/></person-group><article-title>Deleterious impact of &#x0201c;high normal&#x0201d; glucose levels and other metabolic syndrome components on arterial endothelial function and intima-media thickness in apparently healthy Chinese subjects: the CATHAY study</article-title><source><italic>Arteriosclerosis, Thrombosis, and Vascular Biology</italic></source><year>2004</year><volume>24</volume><issue>4</issue><fpage>739</fpage><lpage>743</lpage></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rask-Madsen</surname><given-names>C</given-names></name><name><surname>Ihlemann</surname><given-names>N</given-names></name><name><surname>Krarup</surname><given-names>T</given-names></name><etal/></person-group><article-title>Insulin therapy improves insulin-stimulated endothelial function in patients with type 2 diabetes and ischemic heart disease</article-title><source><italic>Diabetes</italic></source><year>2001</year><volume>50</volume><fpage>2611</fpage><lpage>2618</lpage><pub-id pub-id-type="pmid">11679442</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beckman</surname><given-names>JA</given-names></name><name><surname>Goldfine</surname><given-names>AB</given-names></name><name><surname>Gordon</surname><given-names>MB</given-names></name><name><surname>Creager</surname><given-names>MA</given-names></name></person-group><article-title>Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans</article-title><source><italic>Circulation</italic></source><year>2001</year><volume>103</volume><issue>12</issue><fpage>1618</fpage><lpage>1623</lpage><pub-id pub-id-type="pmid">11273987</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardillo</surname><given-names>C</given-names></name><name><surname>Kilcoyne</surname><given-names>CM</given-names></name><name><surname>Nambi</surname><given-names>SS</given-names></name><name><surname>Cannon</surname><given-names>RO</given-names><suffix>III</suffix></name><name><surname>Quon</surname><given-names>MJ</given-names></name><name><surname>Panza</surname><given-names>JA</given-names></name></person-group><article-title>Vasodilator response to systemic but not to local hyperinsulinemia in the human forearm</article-title><source><italic>Hypertension</italic></source><year>1998</year><volume>32</volume><issue>4</issue><fpage>740</fpage><lpage>745</lpage><pub-id pub-id-type="pmid">9774373</pub-id></element-citation></ref><ref id="B50"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceriello</surname><given-names>A</given-names></name><name><surname>Taboga</surname><given-names>C</given-names></name><name><surname>Tonutti</surname><given-names>L</given-names></name><etal/></person-group><article-title>Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment</article-title><source><italic>Circulation</italic></source><year>2002</year><volume>106</volume><issue>10</issue><fpage>1211</fpage><lpage>1218</lpage><pub-id pub-id-type="pmid">12208795</pub-id></element-citation></ref><ref id="B51"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>J-H</given-names></name><name><surname>Bassenge</surname><given-names>E</given-names></name><name><surname>Kim</surname><given-names>K-B</given-names></name><etal/></person-group><article-title>Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress</article-title><source><italic>Atherosclerosis</italic></source><year>2001</year><volume>155</volume><issue>2</issue><fpage>517</fpage><lpage>523</lpage><pub-id pub-id-type="pmid">11254924</pub-id></element-citation></ref><ref id="B52"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanefeld</surname><given-names>M</given-names></name><name><surname>Temelkova-Kurktschiev</surname><given-names>T</given-names></name></person-group><article-title>The postprandial state and the risk of atherosclerosis</article-title><source><italic>Diabetic Medicine</italic></source><year>1997</year><volume>14</volume><issue>supplement 3</issue><fpage>S6</fpage><lpage>S11</lpage><pub-id pub-id-type="pmid">9272607</pub-id></element-citation></ref><ref id="B53"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>RA</given-names></name><name><surname>Evans</surname><given-names>ML</given-names></name><name><surname>Ellis</surname><given-names>GR</given-names></name><etal/></person-group><article-title>The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes</article-title><source><italic>Atherosclerosis</italic></source><year>2001</year><volume>154</volume><issue>2</issue><fpage>475</fpage><lpage>483</lpage><pub-id pub-id-type="pmid">11166782</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Flow chart showing the study sequence during a study day.
FMD1, FMD2, FMD3, and FMD4, respectively. Flow mediated dilation study 
at 1, 2, 3, and 4 hours after glucose/placebo load. FMD0, flow mediated dilation study 
before glucose/placebo load.</p></caption><graphic xlink:href="EDR2008-672021.001"/></fig><table-wrap id="tab1" position="float"><label>Table 1</label><caption><p>Subject characteristics. Data are presented as mean value &#x000b1;
SEM.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Variable</th><th rowspan="1" colspan="1">(<italic>n</italic> = 10)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age (years)</td><td rowspan="1" colspan="1">41.1 &#x000b1; 3.0</td></tr><tr><td rowspan="1" colspan="1">Gender (F/M)</td><td rowspan="1" colspan="1">4/6</td></tr><tr><td rowspan="1" colspan="1">Bo dy mass
index (kg/m<sup>2</sup>)</td><td rowspan="1" colspan="1">23.2 &#x000b1; 0.71</td></tr><tr><td rowspan="1" colspan="1">Waist circumference (cm)</td><td rowspan="1" colspan="1">80.7 &#x000b1; 2.9</td></tr><tr><td rowspan="1" colspan="1">Glucose-fasting (mmol/l)</td><td rowspan="1" colspan="1">4.12 &#x000b1; 0.12</td></tr><tr><td rowspan="1" colspan="1">Glucose-2 hour post-glucose load (mmol/l)</td><td rowspan="1" colspan="1">5.58 &#x000b1; 0.32</td></tr><tr><td rowspan="1" colspan="1">P-fasting insulin (<italic>&#x003bc;</italic>U/ml)</td><td rowspan="1" colspan="1">2.96 &#x000b1; 0.37</td></tr><tr><td rowspan="1" colspan="1">HbA<sub>1c</sub>(%)</td><td rowspan="1" colspan="1">5.06 &#x000b1; 0.2</td></tr><tr><td rowspan="1" colspan="1">P-fasting triglycerides (mmol/l)</td><td rowspan="1" colspan="1">0.75 &#x000b1; 0.1</td></tr><tr><td rowspan="1" colspan="1">P-CRP (mg/l)</td><td rowspan="1" colspan="1">1.14 &#x000b1; 0.1</td></tr><tr><td rowspan="1" colspan="1">HOMA (kg/m<sup>2</sup>)</td><td rowspan="1" colspan="1">0.65 &#x000b1; 0.09</td></tr></tbody></table></table-wrap><table-wrap id="tab2" position="float"><label>Table 2</label><caption><p>Effects of glucose load and placebo load on FMD, blood glucose and plasma insulin. Data
are presented as mean value &#x000b1; SEM.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Times </th><th colspan="2" rowspan="1"> Delta FMD (%) </th><th colspan="2" rowspan="1"> Blood Glucose (mmol/l) </th><th colspan="2" rowspan="1"> Plasma Insulin (<italic>&#x003bc;</italic>U/l) </th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"> Glucose
load </th><th rowspan="1" colspan="1"> Placebo
load </th><th rowspan="1" colspan="1"> Glucose
load </th><th rowspan="1" colspan="1"> Placebo
load </th><th rowspan="1" colspan="1">Glucose load </th><th rowspan="1" colspan="1"> Placebo
load </th></tr></thead><tbody><tr><td rowspan="1" colspan="1"> Pre-load </td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">4.12 &#x000b1; 0.12</td><td rowspan="1" colspan="1">4.46 &#x000b1; 0.17</td><td rowspan="1" colspan="1">2.96 &#x000b1; 0.37</td><td rowspan="1" colspan="1">4.24 &#x000b1; 0.67</td></tr><tr><td rowspan="1" colspan="1"> 1&#x02009;h </td><td rowspan="1" colspan="1">2.10 &#x000b1; 0.84</td><td rowspan="1" colspan="1">0.19 &#x000b1; 0.70</td><td rowspan="1" colspan="1">6.21 &#x000b1; 0.79</td><td rowspan="1" colspan="1">4.54 &#x000b1; 0.15</td><td rowspan="1" colspan="1">34.42 &#x000b1; 4.99</td><td rowspan="1" colspan="1">3.30 &#x000b1; 0.55</td></tr><tr><td rowspan="1" colspan="1">2 h</td><td rowspan="1" colspan="1">0.65 &#x000b1; 0.85</td><td rowspan="1" colspan="1">1.66 &#x000b1; 0.84</td><td rowspan="1" colspan="1">5.58 &#x000b1; 0.32</td><td rowspan="1" colspan="1">4.64 &#x000b1; 0.19</td><td rowspan="1" colspan="1">27.24 &#x000b1; 3.03</td><td rowspan="1" colspan="1">2.89 &#x000b1; 0.48</td></tr><tr><td rowspan="1" colspan="1"> 3&#x02009;h </td><td rowspan="1" colspan="1">4.80 &#x000b1; 1.4</td><td rowspan="1" colspan="1">2.34 &#x000b1; 1.47</td><td rowspan="1" colspan="1">4.23 &#x000b1; 0.37</td><td rowspan="1" colspan="1">4.53 &#x000b1; 0.17</td><td rowspan="1" colspan="1">12.67 &#x000b1; 2.54</td><td rowspan="1" colspan="1">3.44 &#x000b1; 0.82</td></tr><tr><td rowspan="1" colspan="1">4 h</td><td rowspan="1" colspan="1">2.0 &#x000b1; 1.39</td><td rowspan="1" colspan="1">0.9 &#x000b1; 1.44</td><td rowspan="1" colspan="1">3.35 &#x000b1; 0.17</td><td rowspan="1" colspan="1">4.27 &#x000b1; 0.18</td><td rowspan="1" colspan="1">4.81 &#x000b1; 0.88</td><td rowspan="1" colspan="1">2.90 &#x000b1; 0.58</td></tr></tbody></table></table-wrap></floats-group></article>